Press Releases

New Data in Journal Obesity Demonstrate that a Noninvasive, Removable Medical Device Results in Substantial Weight Loss and Glucose Normalization in a Preclinical Model of Obesity

Data Support Weight Loss and Glucose Results Observed in Clinical Trials of EndoBarrier™; Study Recognized by Obesity Society at 2008 Annual Meeting  LEXINGTON, Mass., November 18, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2...

read more

GI Dynamics to Present Data from Clinical Weight Loss Study of EndoBarrier™ Gastrointestinal Liner in Morbidly Obese Patients at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress

(IFSO) 13th World Congress LEXINGTON, Mass., September 19, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to...

read more

Data from Clinical Trial of EndoBarrier™ Gastrointestinal Liner in Patients with Type 2 Diabetes to be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York

LEXINGTON, Mass., September 9, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2...

read more
Page 18 of 18« First...10...1415161718